NCT04752267
- Conditions
- Adenocarcinoma, Anatomic Stage IV Breast Cancer AJCC v8, Brain Diseases, +65 more
- Locations
-
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
Clinical trial condition
Stage IV Renal Cell Cancer AJCC v8
Explore clinical trials studying Stage IV Renal Cell Cancer AJCC v8. Study availability and eligibility vary by location and protocol.
49 public trials
20 recruiting studies
Stage IV Renal Cell Cancer AJCC v8 trial results
Active, Not Recruiting
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
NCT03793166
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +27 more
- Locations
-
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
Active, Not Recruiting
Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma
NCT06049576
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, Not Recruiting
Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
NCT02298959
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +60 more
- Locations
-
- Moffitt Cancer Center-International Plaza Tampa, Florida, United States
- Moffitt Cancer Center - McKinley Campus Tampa, Florida, United States
- Moffitt Cancer Center Tampa, Florida, United States
- National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
Active, Not Recruiting
Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study
NCT05863351
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- UCHealth University of Colorado Hospital Aurora, Colorado, United States
- Poudre Valley Hospital Fort Collins, Colorado, United States
Active, Not Recruiting
Cancer and Blood Pressure Management, CARISMA Study
NCT04467021
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +36 more
- Locations
-
- Siteman Cancer Center at West County Hospital Creve Coeur, Missouri, United States
- Washington University School of Medicine St Louis, Missouri, United States
- Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
- Montefiore Medical Center-Weiler Hospital The Bronx, New York, United States
Active, Not Recruiting
Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma
NCT03541902
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +22 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
- MD Anderson Regional Care Center-Katy Houston, Texas, United States
- MD Anderson Regional Care Center-Sugar Land Sugar Land, Texas, United States
Active, Not Recruiting
Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
NCT03587662
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC)
NCT03595124
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- CTCA at Western Regional Medical Center Goodyear, Arizona, United States
- Cancer Center at Saint Joseph's Phoenix, Arizona, United States
- CHI Saint Vincent Cancer Center Hot Springs Hot Springs, Arkansas, United States
Active, Not Recruiting
Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study
NCT04071223
- Conditions
- Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +22 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Rush MD Anderson Cancer Center Chicago, Illinois, United States